NIH-funded research R01 grant

Investigating how specific proteins affect retinal cell development

Official title: Homeostasis of the Retinal Epigenome

Funded at Washington University · NIH-10938189 · Data updated 2026-11-12

This study is looking at how a special protein called H3.3 affects the growth of retinal cells, which could help us understand why some people lose their vision, and it might lead to new ways to help those with retinal diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 1, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$388,750
NIH project number1R01EY036368-01
Project IDNIH-10938189 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with genetic predispositions to retinal diseases or those experiencing vision loss.

Less likely to help

Patients with retinal conditions unrelated to genetic factors or those who do not have a family history of retinal disorders may not benefit from this research.

What this research studies

This research focuses on understanding the role of a specific protein variant, H3.3, in the development of retinal cells. By examining how this protein influences the differentiation and fate of retinal cells, the researchers aim to uncover mechanisms that could lead to vision loss. The study employs advanced techniques to analyze genetic modifications and their effects on retinal cell types, using mouse models to simulate human conditions. Patients may benefit from insights gained about retinal diseases linked to these genetic factors.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating vision loss associated with retinal disorders.

How similar studies have gone: Other research has shown promising results in understanding the role of epigenetic modifications in retinal development, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Ruzycki, Philip Andrew — Washington University
  • Study coordinator: Ruzycki, Philip Andrew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.